Back

Mineralocorticoid receptor antagonist drugs in HFpEF

30 August 2025 (11:15 - 11:30)
Organised by: Logo
Congress Presentation Part of: The therapeutic conundrum in HFpEF Chronic Heart Failure ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Maria Generosa Crespo-Leiro

CHUAC, A Coruna (Spain)

3 More presentations in this session

Presentation thumbnail
Mechanistic insights of SGLT2 inhibitors effectiveness
Professor G. Dan (Bucharest, RO)
Slides Video
Presentation thumbnail
Pharmacotherapy targeting inflammation in HFpEF
Professor K. Hasegawa (Kyoto, JP)
Slides Video
Presentation thumbnail
GLP-1 receptor agonist (GLP-1 RA) and gastric inhibitory polypeptides (GIPs) in HFpEF
Professor T. McDonagh (London, GB)
Slides Video

Access the full session

Session thumbnail
The therapeutic conundrum in HFpEF
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Non-steroidal mineralocorticoid receptor antagonists (MRAs): standard therapy for HFpEF?
thumbnail
Congress Presentation
Non-steroidal MRAs in heart failure and cardio-kidney-metabolic disease: current clinical trial evidence
thumbnail
Congress Presentation
Non-steroidal mineralocorticoid receptor antagonists (nsMRAs) in heart failure with mid-range and preserved ejection fraction: establishing a new standard in heart failure care

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources